Noninterventional Study Evaluating Parkinson's Disease Diary Use (NCT05363046)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (34 Sites)

Showing the first 25 of 34 sites.

• Mayo Clinic Neurology — Scottsdale, Arizona
• David Geffen School of Medicine University of California Los Angeles — Los Angeles, California
• University of California, Irvine — Orange, California
• University of Colorado — Aurora, Colorado
• Movement Disorders Center of Boca Raton — Boca Raton, Florida
• University of Miami Health System — Miami, Florida
• Parkinson's Disease and Movement Disorders Center at Northwestern University Feinberg School of Medicine — Chicago, Illinois
• University of Kansas Medical Center — Kansas City, Kansas
• University of Louisville — Louisville, Kentucky
• Tufts Medical Center — Boston, Massachusetts
• Mount Sinai West — New York, New York
• Weill Cornell Medicine - New York Presbyterian Hospital — New York, New York
• University of Rochester Medical Center — Rochester, New York
• Cleveland Clinic — Cleveland, Ohio
• Vanderbilt University Medical Center — Nashville, Tennessee
• Evergreen Health Medical Center — Kirkland, Washington
• Toronto Western Hospital — Toronto, Ontario
• Dkd Wiesbaden — Wolfach, Baden-Wurttemberg
• Klinikum der Universität München - Campus Grosshadern — Munich, Bavaria
• Technischen Universitaet Muenchen (TUM) — Munich, Bavaria
• Universitätsklinikum Würzburg - Medizinische Klinik — Würzburg, Bavaria
• Klinik und Poliklinik für Neurologie am Standort Marburg — Marburg, Hesse
• Universitaetsklinikum Duesseldorf AöR — Düsseldorf,
• Universitätsmedizin Rostock — Rostock,
• University Hospital Tuebingen — Tübingen,

📞 Contact the Study Coordinator

Phone: (800) 664-4580

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Parkinson's Disease

• Genotypic Influences on Network Progression in Parkinson's Disease — Manhasset, New York
• Efficacy, Safety and Tolerability Study of ND0612 vs. Oral Immediate Release Levodopa/Carbidopa (IR-LD/CD) in Subjects With Parkinson's Disease Experiencing Motor Fluctuations — Phoenix, Arizona
• Long-term Follow-up of Glutamic Acid Decarboxylase (GAD) Gene Transfer in Parkinson's Disease — New Haven, Connecticut
• Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in GBA-PD — Phoenix, Arizona
• Cont. of a Study to Evaluate Implanting Peripheral Nerve Grafts Into Subjects With Parkinson's Disease (PD) During DBS — Lexington, Kentucky
• ExAblate Transcranial MRgFUS for Unilateral Pallidotomy for the Treatment of Parkinson's Disease — Toronto, Ontario

Explore by condition: All Parkinson's Disease clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.